Avid Radiopharma Raises $26 Million

Avid Radiopharmaceuticals Inc., a Philadelphia-based molecular imaging company, has raised $26 million in Series C funding. Safeguard Scienfitics and AllianceBernstein co-led the deal, and were joined by BioAdvance, Lilly Ventures, Pfizer and RK Venture Group. The company previously had raised around $9.4 million in total VC funding. www.avidrp.com